Nicholas Mitsiades
Medical Oncology · Regents of the Univ of Ca
Credentials: · · ·
History
- 1995
University of Athens School of Medicine
Research
Integrative genomic profiling of human prostate cancer
Cancer Cell · 2010 · 3,097 citations
NF-kappa B as a therapeutic target in multiple myeloma
Journal of Biological Chemistry · 2002 · 795 citations
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Proceedings of the National Academy of Sciences of the United States of America · 2002 · First of 14 authors · 623 citations
55 papers
41 papers
35 papers
- VP
17 papers · 6 as a resident
16 papers
- CM
13 papers · 6 as a resident
- RS
12 papers
10 papers
Grants
- 2018–2024
The Rna Helicase eif4a Is a Therapeutic Vulnerability in Triple-Negative Breast Cancer
National Cancer Institute · U54
Contact PI · $3.5M · Baylor College of Medicine
- 2015–2020
Regulation of Uveal Melanoma Cell Fate by the Pkc Pathway via Mitf
National Cancer Institute · R01
Contact PI · $1.8M · Baylor College of Medicine
Clinical trials
- 2012–2014
Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Principal investigator · Withdrawn · Phase 2
Nicholas Mitsiades
- 2025–2034
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology